Beschreibung
Metabolite-specific mediation result (Figure 52) quantifying the proportion of the omega-3 PUFA effect on IBD that operates through a particular circulating metabolite pathway.
Figure 52
ChartSource Paper
Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study.Cite This Figure
![Figure 52: Metabolite-specific mediation result (Figure 52) quantifying the proportion of the omega-3 PUFA effect on IBD that operates through a particular circulating metabolite pathway.]() > Source: Xiaojing Jia et al. "Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bo." *Metabolites*, 2023. PMID: [37887366](https://pubmed.ncbi.nlm.nih.gov/37887366/)
<figure> <img src="" alt="Metabolite-specific mediation result (Figure 52) quantifying the proportion of the omega-3 PUFA effect on IBD that operates through a particular circulating metabolite pathway." /> <figcaption>Figure 52. Metabolite-specific mediation result (Figure 52) quantifying the proportion of the omega-3 PUFA effect on IBD that operates through a particular circulating metabolite pathway.<br> Source: Xiaojing Jia et al. "Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bo." <em>Metabolites</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37887366/">37887366</a></figcaption> </figure>